SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-17-000144
Filing Date
2017-01-06
Accepted
2017-01-06 17:19:25
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 fate-s3_20170106.htm S-3 353372
2 EX-5.1 fate-ex51_6.htm EX-5 8651
3 EX-23.1 fate-ex231_37.htm EX-23 2539
4 GRAPHIC g201701062025064367821.jpg GRAPHIC 2812
5 GRAPHIC g201701062025207836945.jpg GRAPHIC 2472
6 GRAPHIC g201701062025237826946.jpg GRAPHIC 2472
  Complete submission text file 0001564590-17-000144.txt   376752
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-215460 | Film No.: 17515103
SIC: 2836 Biological Products, (No Diagnostic Substances)